1 Fletcher, D. S., "Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats" 284 : 714-721, 1998
2 Lee, D. K., "Temporal relationships of the anti-inflammatory effects of etodolac in the adjuvant arthritic rat" 187 : 273-277, 1988
3 McDermott, M. F., "TNF and TNFR biology in health and disease" 47 : 619-635, 2001
4 Taniguch, N., "Study on application of static magnetic field for adjuvant arthritis rats" 1 : 187-191, 2004
5 Anderson, G. D., "Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis" 97 : 2672-2679, 1996
6 Harada, Y., "Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenininduced pleurisy" 51 : 19-33, 1996
7 Williams, A. S., "Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate" 12 : 54-58, 1994
8 Barnes, D. A., "Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model" 101 : 2910-2919, 1998
9 Salvemini, D., "Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology" 95 : 2659-2663, 1998
10 Botting, R. M, "Pathogenesis and mechanisms of inflammation and pain" 19 (19): 1-7, 2000
1 Fletcher, D. S., "Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats" 284 : 714-721, 1998
2 Lee, D. K., "Temporal relationships of the anti-inflammatory effects of etodolac in the adjuvant arthritic rat" 187 : 273-277, 1988
3 McDermott, M. F., "TNF and TNFR biology in health and disease" 47 : 619-635, 2001
4 Taniguch, N., "Study on application of static magnetic field for adjuvant arthritis rats" 1 : 187-191, 2004
5 Anderson, G. D., "Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis" 97 : 2672-2679, 1996
6 Harada, Y., "Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenininduced pleurisy" 51 : 19-33, 1996
7 Williams, A. S., "Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate" 12 : 54-58, 1994
8 Barnes, D. A., "Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model" 101 : 2910-2919, 1998
9 Salvemini, D., "Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology" 95 : 2659-2663, 1998
10 Botting, R. M, "Pathogenesis and mechanisms of inflammation and pain" 19 (19): 1-7, 2000
11 Tanahashi, M., "Inhibitory effect of TKR-530 on rat adjuvant arthritis" 56 : 242-251, 1998
12 Harbuz, M. S., "Hypothalamo-pituitary-adrenal axis responses to lipopolyshaccharide in male and female rats with adjuvant-induced arthritis" 13 : 335-347, 1999
13 Fedatto, J. Z., "Gluconeogenesis in the liver of arthritic rats" 17 : 271-278, 1999
14 Paulos, C. M., "Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis" 8 : 1-10, 2006
15 Egan, C. G., "Expression of constitutive but not inducible cyclooxygenase maintains articular perfusion in the rat knee" 86 : 191-197, 2001
16 Hidaka, T., "Effect of alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gammabutyrolactone (KME-4), a new anti-inflammatory drug, on the established adjuvant arthritis in rats" 42 : 181-187, 1986
17 Bruot, B. C., "Effect of adjuvant-induced arthritis on serum luteinizing hormone and testosterone concentrations in the male rat" 41 : 1559-1565, 1987
18 Langengger, T., "Drug treatment for rheumatoid arthritis" 366 : 22-30, 1999
19 Kazemekaite, M., "Diazoamino coupling of a sulfobenzenediazonium salt with some cyclic amines" 7 : 706-711, 2002
20 Dinarello, C. A., "Cytokines in the inflammatory response. In: Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis" Amgen. Inc. 3-21, 2000
21 Sarlis, N. J., "Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat" 130 : 1775-1779, 1992
22 Halloran, M. M., "Cellular adhesion molecules in rat adjuvant arthritis" 39 : 810-819, 1996
23 Crofford, L., "COX-1 and COX-2 tissue expression: Implications and predictions" 24 (24): 15-19, 1997
24 Theisen-Popp, P., "Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis" 42 : 50-55, 1994
25 Helyes, Z., "Anti-inflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund’s adjuvant-induced chronic arthritis model in the rat" 50 : 1677-1685, 2004
26 Kazemekaite, M., "Anti-inflammatory action of sulfoaryl 3,3-disubstituted triazenes in rat experimental edema models" 58 : 730-732, 2003
27 Wooley, P. H., "Animal models of rheumatoid arthritis" 3 : 407-420, 1991
28 Day, R. O., "Adverse drug reactions and their measurement in the rheumatic diseases" 22 : 983-988, 1995
29 Wauben, M. H., "Adjuvant arthritis In: Autoimmune disease models: a guidebook" Academic Press Inc. 201-216, 1994
30 Yamaguchi, Y., "Abnormal lipid metabolism in adjuvant arthritic rats" 50 : 377-386, 1989